CTX
vs
S
S&P TSX Composite Index (Canada)
CTX
Over the past 12 months, CTX has underperformed S&P TSX Composite Index (Canada), delivering a return of -24% compared to the S&P TSX Composite Index (Canada)'s +28% growth.
Stocks Performance
CTX vs S&P TSX Composite Index (Canada)
Performance Gap
CTX vs S&P TSX Composite Index (Canada)
Performance By Year
CTX vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Crescita Therapeutics Inc
Glance View
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. The company is headquartered in Mississauga, Ontario and currently employs 69 full-time employees. The company went IPO on 2016-03-07. The firm offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. The firm operates through three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products in both the Canadian and international markets. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis, MMPE and DuraPeel, on either an exclusive or non-exclusive basis. The Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization (CDMO) infrastructure, and sales of product development services.